Alka-Seltzer Plus Cold Formula Sparkling Original Effervescent Tablets Interactions
There are 787 drugs known to interact with Alka-Seltzer Plus Cold Formula Sparkling Original Effervescent Tablets (aspirin/chlorpheniramine/phenylephrine), along with 17 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 99 are major, 666 are moderate, and 22 are minor.
- View all 787 medications that may interact with Alka-Seltzer Plus Cold Formula Sparkling Original Effervescent Tablets
- View Alka-Seltzer Plus Cold Formula Sparkling Original Effervescent Tablets alcohol/food interactions (1)
- View Alka-Seltzer Plus Cold Formula Sparkling Original Effervescent Tablets disease interactions (17)
Most frequently checked interactions
View interaction reports for Alka-Seltzer Plus Cold Formula Sparkling Original Effervescent Tablets (aspirin / chlorpheniramine / phenylephrine) and the medicines listed below.
- acetaminophen
- albuterol
- Alka-Seltzer Original (aspirin/citric acid/sodium bicarbonate)
- amoxicillin
- atorvastatin
- Benadryl (diphenhydramine)
- benzonatate
- cephalexin
- cyclobenzaprine
- doxycycline
- gabapentin
- ibuprofen
- lisinopril
- losartan
- magnesium oxide
- melatonin
- meloxicam
- metformin
- Mucinex (guaifenesin)
- naproxen
- omeprazole
- pantoprazole
- prednisone
- pseudoephedrine
- tramadol
- Tylenol (acetaminophen)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Xanax (alprazolam)
- Zyrtec (cetirizine)
Alka-Seltzer Plus Cold Formula Sparkling Original Effervescent Tablets alcohol/food interactions
There is 1 alcohol/food interaction with Alka-Seltzer Plus Cold Formula Sparkling Original Effervescent Tablets (aspirin / chlorpheniramine / phenylephrine).
Alka-Seltzer Plus Cold Formula Sparkling Original Effervescent Tablets disease interactions
There are 17 disease interactions with Alka-Seltzer Plus Cold Formula Sparkling Original Effervescent Tablets (aspirin / chlorpheniramine / phenylephrine) which include:
- coagulation
- asthma
- GI toxicity
- renal dysfunction
- Reye's syndrome
- cardiovascular disease
- anticholinergic effects
- asthma/COPD
- cardiovascular
- renal/liver disease
- anemia
- dialysis
- G-6-PD deficiency
- hepatotoxicity
- BPH
- diabetes
- glaucoma
More about Alka-Seltzer Plus Cold Formula Sparkling Original Effervescent Tablets (aspirin / chlorpheniramine / phenylephrine)
- Alka-Seltzer Plus Cold Formula Sparkling Original Effervescent Tablets consumer information
- Compare alternatives
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- Drug class: upper respiratory combinations
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Benadryl
Benadryl is an antihistamine and is used to treat sneezing, runny nose, itching and other ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Promethazine DM
Promethazine DM is used for allergic rhinitis, cold symptoms, cough
Doxylamine
Doxylamine systemic is used for allergic rhinitis, allergies, conjunctivitis, allergic, insomnia ...
Mometasone nasal
Mometasone nasal is used for allergic rhinitis, allergies, nasal polyps, sinus symptoms
Sodium chloride nasal
Sodium chloride nasal is used for nasal congestion
Chlorpheniramine
Chlorpheniramine systemic is used for allergic reactions, allergic rhinitis, allergies, cold ...
Pseudoephedrine
Pseudoephedrine is used to treat nasal and sinus congestion, or congestion of the tubes that drain ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.